Academic Radiology
Volume 13, Issue 6 , Pages 744-751 , June 2006

Enhancing Lesions of the Brain: Intraindividual Crossover Comparison of Contrast Enhancement After Gadobenate Dimeglumine Versus Established Gadolinium Comparators

  • Marco Essig, MD

      Affiliations

    • German Cancer Research Center, Department of Radiology, INF 280, 69120 Heidelberg, Germany
    • Institute for Biological Sciences, Universita’ “G.D. Annunzio” of Chieti-Pescara, Chieti, Italy
    • Istituto di Radiologia, Policlinico A. Gemelli, Roma, Italy
    • Worldwide Medical Affairs, Bracco Diagnostics Inc. Princeton, NJ, USA
    • Worldwide Medical Affairs, Bracco Imaging SpA, Milano, Italy
    • Corresponding Author InformationAddress correspondence to M.E.
    • ,
  • Armando Tartaro, MD

      Affiliations

    • German Cancer Research Center, Department of Radiology, INF 280, 69120 Heidelberg, Germany
    • Institute for Biological Sciences, Universita’ “G.D. Annunzio” of Chieti-Pescara, Chieti, Italy
    • Istituto di Radiologia, Policlinico A. Gemelli, Roma, Italy
    • Worldwide Medical Affairs, Bracco Diagnostics Inc. Princeton, NJ, USA
    • Worldwide Medical Affairs, Bracco Imaging SpA, Milano, Italy
    • ,
  • Tomasso Tartaglione, MD

      Affiliations

    • German Cancer Research Center, Department of Radiology, INF 280, 69120 Heidelberg, Germany
    • Institute for Biological Sciences, Universita’ “G.D. Annunzio” of Chieti-Pescara, Chieti, Italy
    • Istituto di Radiologia, Policlinico A. Gemelli, Roma, Italy
    • Worldwide Medical Affairs, Bracco Diagnostics Inc. Princeton, NJ, USA
    • Worldwide Medical Affairs, Bracco Imaging SpA, Milano, Italy
    • ,
  • Gianpaolo Pirovano, MD

      Affiliations

    • German Cancer Research Center, Department of Radiology, INF 280, 69120 Heidelberg, Germany
    • Institute for Biological Sciences, Universita’ “G.D. Annunzio” of Chieti-Pescara, Chieti, Italy
    • Istituto di Radiologia, Policlinico A. Gemelli, Roma, Italy
    • Worldwide Medical Affairs, Bracco Diagnostics Inc. Princeton, NJ, USA
    • Worldwide Medical Affairs, Bracco Imaging SpA, Milano, Italy
    • ,
  • Miles A. Kirchin, PhD

      Affiliations

    • German Cancer Research Center, Department of Radiology, INF 280, 69120 Heidelberg, Germany
    • Institute for Biological Sciences, Universita’ “G.D. Annunzio” of Chieti-Pescara, Chieti, Italy
    • Istituto di Radiologia, Policlinico A. Gemelli, Roma, Italy
    • Worldwide Medical Affairs, Bracco Diagnostics Inc. Princeton, NJ, USA
    • Worldwide Medical Affairs, Bracco Imaging SpA, Milano, Italy
    • ,
  • Alberto Spinazzi, MD

      Affiliations

    • German Cancer Research Center, Department of Radiology, INF 280, 69120 Heidelberg, Germany
    • Institute for Biological Sciences, Universita’ “G.D. Annunzio” of Chieti-Pescara, Chieti, Italy
    • Istituto di Radiologia, Policlinico A. Gemelli, Roma, Italy
    • Worldwide Medical Affairs, Bracco Diagnostics Inc. Princeton, NJ, USA
    • Worldwide Medical Affairs, Bracco Imaging SpA, Milano, Italy

Received 28 February 2005 ,Revised 28 February 2005 ,Accepted 28 February 2005.

References 

  1. Brant-Zawadski M , Norman D , Newton TH . Magnetic resonance imaging of the brain (the optimal screening technique) . Radiology . 1984;152:71–77
  2. Muroff LR , Runge VM . The use of MR contrast in neoplastic disease of the brain . Top Magn Reson Imaging . 1995;7:137–157
  3. Edelmann RR , Hesselink JR , Zlatkin MB . Clinical Magnetic Resonance Imaging . 2nd ed.. Philadelphia: WB Saunders; 1996;
  4. Essig M, Knopp MV, Schoenberg SO, Hawighorst H, Wenz F, Debus J, et al. Contrast enhanced fast fluid-attenuated inversion-recovery (FLAIR) MR imaging in the assessment of primary glial tumors and brain metastases . Radiology . 1999;210:551–557
  5. Erickson BJ , Campeau NG , Schreiner SA , Buckner JC , O’Neill BP , O’Fallon JR . Triple-dose contrast/magnetization transfer suppressed imaging of ‘non-enhancing’ brain gliomas . J Neurooncol . 2002;60:25–29
  6. Schneider G , Kirchin MA , Pirovano G , et al.   Gadobenate dimeglumine-enhanced magnetic resonance imaging of intracranial metastases (Effect of dose on lesion detection and delineation) . J Magn Reson Imaging . 2001;14:525–539
  7. de Haën C , Cabrini M , Akhnana L , Ratti D , Calabi L , Gozzini L . Gadobenate dimeglumine 0.5 M solution for injection (MultiHance) (Pharmaceutical formulation and physicochemical properties of a new magnetic resonance imaging contrast medium) . J Comput Assist Tomogr . 1999;23(suppl. 1):161–168
  8. Rohrer M , Bauer H , Mintorovitch J , Requardt M , Weinmann HJ . Comparison of magnetic properties of MRI contrast media solutions at different magnetic field strengths . Invest Radiol . 2005;40:715–724
  9. Yuh WTC , Fisher DJ , Engelken JD , et al.   MR evaluation of CNS tumors (dose comparison study with gadopentetate dimeglumine and gadoteridol) . Radiology . 1991;180:485–491
  10. Myhr G , Rinck PA , Børseth A . Gadodiamide injection and gadopentetate dimeglumine (A double-blind study in MR imaging of the CNS) . Acta Radiol . 1992;33:405–409
  11. Valk J , Algra PR , Hazenberg CJ , Slooff WBM , Slavand MG . A double-blind, comparative study of gadodiamide injection and gadopentetate dimeglumine in MRI of the central nervous system . Neuroradiology . 1993;35:173–177
  12. Oudkerk M , Sijens PE , van Beek EJ , Kuijpers TJ . Safety and efficacy of Dotarem (Gd-DOTA) versus Magnevist (Gd-DTPA) in magnetic resonance imaging of the central nervous system . Invest Radiol . 1995;30:75–78
  13. Grossman RI , Rubin DL , Hunter G , et al.   Magnetic resonance imaging in patients with central nervous system pathology (A comparison of OptiMARK (Gd-DTPA-BMEA) and Magnevist (Gd-DTPA)) . Invest Radiol . 2000;35:412–419
  14. Greco A , Parker JR , Ratcliffe CG , Kirchin MA , McNamara MT . Phase III, randomized, double-blind, cross-over comparison of gadoteridol and gadopentetate dimeglumine in magnetic resonance imaging of patients with intracranial lesions . Australas Radiol . 2001;45:457–463
  15. Kirchin MA , Pirovano G , Venetianer C , Spinazzi A . Safety assessment of gadobenate dimeglumine (Multihance®) (Extended clinical experience from phase I studies to postmarketing surveillance) . J Magn Reson Imaging . 2001;14:281–294
  16. Spinazzi A , Lorusso V , Pirovano G , Kirchin M . Safety, tolerance, biodistribution and MR imaging enhancement of the liver with gadobenate dimeglumine . Acad Radiol . 1999;6:282–291
  17. Cavagna FM , Maggioni F , Castelli PM , et al.   Gd chelates with weak binding to serum proteins. A new class of high-efficiency, general purpose contrast agents for magnetic resonance imaging . Invest Radiol . 1997;32:780–796
  18. Pintaske J , Martirosian P , Graf H , et al.   Relaxivity of gadopentetate dimeglumine (Magnevist), gadobutrol (Gadovist) and gadobenate dimeglumine (MultiHance) in human blood plasma at 0.2 T, 1.5 T and 3 T . Invest Radiol . 2006;41:213–221
  19. Colosimo C , Ruscalleda J , Korves M , et al.   Detection of intracranial metastases (A multi-center, intrapatient comparison of gadobenate dimeglumine-enhanced MRI with routinely used contrast agents at equal dose) . Invest Radiol . 2001;36:72–81
  20. Knopp MV , Runge VM , Essig M , et al.   Primary and secondary brain tumors at MR imaging (bicentric intraindividual crossover comparison of gadobenate dimeglumine and gadopentetate dimeglumine) . Radiology . 2004;230:55–64
  21. Colosimo C , Knopp MV , Barreau X , et al.   Is increased relaxivity beneficial for contrast-enhanced MR imaging of brain tumors? Blinded intraindividual comparison of gadobenate dimeglumine and Gd-DOTA . Neuroradiology . 2004;46:655–665
  22. Knopp MV , Schoenberg SO , Rehm C , et al.   Assessment of gadobenate dimeglumine (Gd-BOPTA) for MR angiography (Phase I studies) . Invest Radiol . 2002;37:706–715
  23. Knopp MV , Giesel FL , von Tengg-Kobligk H , et al.   Contrast-enhanced MR angiography of the run-off vasculature (Intraindividual comparison of gadobenate dimeglumine with gadopentetate dimeglumine) . J Magn Reson Imaging . 2003;17:694–702
  24. Prokop M , Schneider G , Vanzulli A , et al.   Contrast-enhanced MR angiography of the renal arteries (Blinded multicenter crossover comparison of gadobenate dimeglumine and gadopentetate dimeglumine) . Radiology . 2005;234:399–408
  25. Schneider G , Maas R , Schultze Kool L , et al.   Low-dose gadobenate dimeglumine versus standard dose gadopentetate dimeglumine for contrast-enhanced magnetic resonance imaging of the liver (An intraindividual crossover comparison) . Invest Radiol . 2003;38:85–94
  26. Pediconi F , Catalano C , Occhiato R , et al.   Breast lesion detection and characterization at contrast-enhanced MR mammography (Gadobenate dimeglumine versus gadopentetate dimeglumine) . Radiology . 2005;237:45–56
  27. Giesel FL , von Tengg-Kobligk H , Wilkinson ID , et al.   Influence of human serum albumin on longitudinal and transverse relaxation rates (R1 & R2) of MR contrast agents . Invest Radiol . 2006;41:222–228
  28. de Haën C , Gozzini L . Soluble-type hepatobiliary contrast agents for MR imaging . J Magn Reson Imaging . 1993;3:179–186
  29. Banci L , Bertini I , Luchinat C . In: Nuclear and Electron Relaxation . Weinheim, Germany: VCH Verlagsgesellschaft mbH; 1991;p. 138
  30. Yuh WT , Tali ET , Nguyen HD , Simonson TM , Mayr NA , Fisher DJ . The effect of contrast dose, imaging time, and lesion size in the MR detection of intracerebral metastasis . AJNR Am J Neuroradiol . 1995;16:373–380
  31. Schörner W , Laniado M , Niendorf HP , Schubert C , Felix R . Time-dependent changes in image contrast in brain tumors after gadolinium-DTPA . AJNR Am J Neuroradiol . 1986;7:1013–1020
  32. Seitz RJ , Wechsler W . Immunohistochemical demonstration of serum proteins in human cerebral gliomas . Acta Neuropathol (Berl) . 1987;73:145–152
  33. Kirchin MA , Runge VM . Contrast agents for magnetic resonance imaging (Safety update) . Top Magn Reson Imaging . 2003;14:426–435

PII: S1076-6332(06)00168-1

doi: 10.1016/j.acra.2006.02.056

Academic Radiology
Volume 13, Issue 6 , Pages 744-751 , June 2006

Article Tools

* Image Usage & Resolution